TK1 and central nervous system cancer: Time-dependent ROC curves indicated that TK1 expression had a high diagnostic value of TK1 expression in glioma patients, with an area under the curve (AUC) of 0.682, 0.735, 0.758 for 1-year, 3-year, and 5-year survival, respectively (Figure 4A).